ROYCE & ASSOCIATES LP - CHEMBIO DIAGNOSTICS INC ownership

CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 80 filers reported holding CHEMBIO DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 2.48 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of CHEMBIO DIAGNOSTICS INC
ValueSharesWeighting
Q3 2022$49,000
-44.3%
135,8000.0%0.00%0.0%
Q2 2022$88,000
-20.7%
135,8000.0%0.00%0.0%
Q1 2022$111,000
-69.0%
135,800
-56.8%
0.00%
-66.7%
Q4 2021$358,000
-70.9%
314,353
-36.0%
0.00%
-66.7%
Q3 2021$1,229,000
-15.8%
491,4530.0%0.01%
-10.0%
Q2 2021$1,460,000
-15.4%
491,4530.0%0.01%
-16.7%
Q1 2021$1,725,000
-26.1%
491,4530.0%0.01%
-36.8%
Q4 2020$2,334,000
-2.3%
491,4530.0%0.02%
-26.9%
Q3 2020$2,388,000
+25.8%
491,453
-15.9%
0.03%
+23.8%
Q2 2020$1,899,000
-68.4%
584,342
-50.3%
0.02%
-74.4%
Q1 2020$6,018,000
+33.1%
1,175,316
+18.5%
0.08%
+105.0%
Q4 2019$4,521,000
+20.0%
991,492
+61.1%
0.04%
+14.3%
Q3 2019$3,768,000
+31.9%
615,618
+31.2%
0.04%
+34.6%
Q2 2019$2,857,000
+9.7%
469,1530.0%0.03%
+18.2%
Q1 2019$2,604,000
-1.9%
469,1530.0%0.02%
-8.3%
Q4 2018$2,655,000
-20.8%
469,153
+47.0%
0.02%
+4.3%
Q3 2018$3,351,000
+0.8%
319,153
+6.6%
0.02%0.0%
Q2 2018$3,323,000
+92.9%
299,353
+39.0%
0.02%
+91.7%
Q1 2018$1,723,000
+105.1%
215,353
+110.3%
0.01%
+100.0%
Q4 2017$840,000
+517.6%
102,400
+367.6%
0.01%
+500.0%
Q3 2017$136,000
+3.0%
21,9000.0%0.00%0.0%
Q2 2017$132,00021,9000.00%
Other shareholders
CHEMBIO DIAGNOSTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Penbrook Management LLC 344,060$1,634,0001.26%
Union Square Park Capital Management, LLC 400,000$1,900,0000.76%
P.A.W. CAPITAL CORP 100,000$475,0000.42%
PRECEPT MANAGEMENT LLC 150,000$713,0000.29%
Newbridge Financial Services Group, Inc. 73,500$349,0000.29%
SANDERS MORRIS HARRIS LLC 183,584$990,0000.22%
FRIESS ASSOCIATES LLC 555,000$2,636,0000.19%
PERRITT CAPITAL MANAGEMENT INC 30,651$146,0000.09%
Ikarian Capital, LLC 219,109$1,041,0000.05%
SEGALL BRYANT & HAMILL, LLC 705,823$3,352,0000.04%
View complete list of CHEMBIO DIAGNOSTICS INC shareholders